{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:51:08Z","timestamp":1790743868218,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1136\/ard.2011.153718","type":"journal-article","created":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T05:19:07Z","timestamp":1317964747000},"page":"2089-2094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Efficacy of intravenous Ig therapy in juvenile dermatomyositis"],"prefix":"10.1016","volume":"70","author":[{"given":"Catherine G","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Manlhiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor M","family":"Pullenayegum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2011.153718_bib1","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet"},{"key":"10.1136\/ard.2011.153718_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","article-title":"Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis","volume":"43","author":"Huber","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.153718_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.bor.0000240362.32089.4c","article-title":"Advances in the treatment of juvenile dermatomyositis","volume":"18","author":"Stringer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.2011.153718_bib4","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","author":"Ramanan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.153718_bib5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0887-8994(95)00195-6","article-title":"Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin","volume":"13","author":"Vedanarayanan","year":"1995","journal-title":"Pediatr Neurol"},{"key":"10.1136\/ard.2011.153718_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02230347","article-title":"Efficacy of intravenous immunoglobulin therapy in a case of juvenile dermatomyositis","volume":"15","author":"Galeazzi","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2011.153718_bib7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1442-200x.1999.01132.x","article-title":"Intravenous immunoglobulin treatment in a girl with juvenile dermatomyositis","volume":"41","author":"Kokori","year":"1999","journal-title":"Pediatr Int"},{"key":"10.1136\/ard.2011.153718_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(91)90010-U","article-title":"Treatment of dermatomyositis with intravenous gammaglobulin","volume":"91","author":"Lang","year":"1991","journal-title":"Am J Med"},{"key":"10.1136\/ard.2011.153718_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.72.1.25","article-title":"Intravenous immunoglobulin in juvenile dermatomyositis \u2013 four year review of nine cases","volume":"72","author":"Sansome","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1136\/ard.2011.153718_bib10","first-page":"111","article-title":"Intravenous immunoglobulin therapy in juvenile dermatomyositis","volume":"38","author":"Tsai","year":"1997","journal-title":"Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi"},{"key":"10.1136\/ard.2011.153718_bib11","first-page":"2498","article-title":"Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety","volume":"27","author":"Al-Mayouf","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2011.153718_bib12","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2011.153718_bib13","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3899\/jrheum.090953","article-title":"Treatment approaches to juvenile dermatomyositis (JDM) across North America: the Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey","volume":"37","author":"Stringer","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2011.153718_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1684\/ejd.2008.0580","article-title":"Guidelines on the use of high-dose intravenous immunoglobulin in dermatology","volume":"19","author":"Enk","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1136\/ard.2011.153718_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"10.1136\/ard.2011.153718_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwi208","article-title":"An application of model-fitting procedures for marginal structural models","volume":"162","author":"Mortimer","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1136\/ard.2011.153718_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.10924","article-title":"Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence","volume":"49","author":"Bode","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.153718_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2011.153718_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2011.153718_bib20","first-page":"1106","article-title":"Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group","volume":"28","author":"Huber","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2011.153718_bib21","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/1529-0131(200108)44:8<1768::AID-ART312>3.0.CO;2-Q","article-title":"The clinical meaning of functional outcome scores in children with juvenile arthritis","volume":"44","author":"Dempster","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.153718_bib22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jclinepi.2007.10.024","article-title":"Fitting marginal structural models: estimating covariate-treatment associations in the reweighted data set can guide model fitting","volume":"61","author":"Pullenayegum","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ard.2011.153718_bib23","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1542\/peds.2007-1218","article-title":"Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content","volume":"121","author":"Manlhiot","year":"2008","journal-title":"Pediatrics"},{"key":"10.1136\/ard.2011.153718_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pcl.2005.01.004","article-title":"Inflammatory myopathies in children","volume":"52","author":"Compeyrot-Lacassagne","year":"2005","journal-title":"Pediatr Clin North Am"},{"key":"10.1136\/ard.2011.153718_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/ard.2011.153718_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.intimp.2005.11.016","article-title":"The role of high-dose immune globulin intravenous in the treatment of dermatomyositis","volume":"6","author":"Dalakas","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1136\/ard.2011.153718_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/08916930600622553","article-title":"Clinical assessment in juvenile dermatomyositis","volume":"39","author":"Ravelli","year":"2006","journal-title":"Autoimmunity"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724190413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724190413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2011.153718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:07:29Z","timestamp":1737248849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724190413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0003496724190413"],"URL":"https:\/\/doi.org\/10.1136\/ard.2011.153718","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of intravenous Ig therapy in juvenile dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2011.153718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}